Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Cited by (1,093)

Items 801–900 of 1,093

1. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
   Viveca Ritsinger, Klas Malmberg, Anton Mårtensson, Lars Rydén, Hans Wedel, Anna Norhammar · 2014 · The Lancet Diabetes & Endocrinology
2. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications
   Antonio Ceriello, Roberto Testa, Stefano Genovese · 2016 · Nutrition Metabolism and Cardiovascular Diseases
3. Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study
   Mariam P. Alexander, Tejas V. Patel, Youssef M K Farag, Adriana Flórez, Helmut G. Rennke, Ajay K. Singh · 2009 · American Journal of Kidney Diseases
4. The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
   Scirica, Benjamin M., Bhatt, Deepak L., Braunwald, Eugene, Steg, Ph. Gabriel, Davidson, Jaime, Hirshberg, Boaz, Ohman, Peter, Price, Deborah L., Chen, Roland, Udell, Jacob et al. · 2011 · American Heart Journal
5. Vascular complications in diabetes: Old messages, new thoughts
   Forbes, Josephine M., Fotheringham, Amelia K. · 2017 · Diabetologia
6. Current controversies in the use of haemoglobin A1c
   Matthew J. L. Hare, Jonathan E. Shaw, Paul Zimmet · 2011 · Journal of Internal Medicine
7. Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes
   Susanna C. Larsson, Robert A. Scott, Matthew Traylor, Claudia Langenberg, George Hindy, Olle Melander, Marju Orho‐Melander, Sudha S. Seshadri, Nicholas J. Wareham, Hugh Stephen Markus · 2017 · Neurology
8. Hypertension in patients with type 2 diabetes mellitus: Targets and management
   Dimitra I. Pavlou, Stavroula Α. Paschou, Panagiotis G. Anagnostis, Μichael Spartalis, Eleftherios D Spartalis, Andromachi Vryonidou, Nikolaοs Tentolouris, Gerasimos Siasos · 2018 · Maturitas
9. Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes
   David R. Owens · 2013 · Diabetes Technology & Therapeutics
10. Diabetes and Metabolism
    Alicia Juliana Kowaltowski, Fernando Abdulkader · 2020 · Springer eBooks
11. Intensive versus intermediate glucose control in surgical intensive care unit patients
    Okabayashi, Takehiro, Shima, Yasuo, Sumiyoshi, Tatsuaki, Kozuki, Akihito, Tokumaru, Teppei, Iiyama, Tasuo, Sugimoto, Takeki, Kobayashi, Michiya, Yokoyama, Masataka, Hanazaki, Kazuhiro · 2014 · Diabetes Care
12. Pharmacological Treatment and Current Management of Peripheral Artery Disease
    Marc P. Bonaca, Mark A. Creager · 2015 · Circulation Research
13. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies
    Germaine Wong, Natalie Staplin, Jonathan Emberson, Colin Baigent, Robin M. Turner, John Philip Chalmers, Sophia Zoungas, Carol A. Pollock, Bruce A. Cooper, David A. Harris et al. · 2016 · BMC Cancer
14. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial
    Liping Yang, Wenhua Ling, Yan Yang, Yu‐Ming Chen, Zezhong Tian, Zhicheng Du, Jianying Chen, Yuanling Xie, Zhaomin Liu, Changyi Wang · 2017 · Nutrients
15. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
    Jean‐Pierre Bassand, Gabriele Accetta, Wael A. Almahmeed, Ramon L. Corbalan, John W. Eikelboom, David Andrew Fitzmaurice, Keith A.A. Fox, Haiyan Gao, Samuel Zachary Goldhaber, Shinya Goto et al. · 2018 · PLoS ONE
16. Chronic Kidney Disease in Diabetes
    Philip A. McFarlane, David Z.I. Cherney, Richard E. Gilbert, Peter Alexander Senior · 2018 · Canadian Journal of Diabetes
17. Association of Glycemic Control with Risk of Erectile Dysfunction in Men with Type 2 Diabetes
    Chih-Chen Lu, Bang‐Ping Jiann, Chun-Chin Sun, Hing‐Chung Lam, Chih-Hsun Chu, Jenn‐Kuen Lee · 2009 · The Journal of Sexual Medicine
18. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
    Michaela Beatrice Rehman, Benoit Valentin Tudrej, J. Soustre, Marielle Buisson, P. Archambault, Denis Pouchain, Hélène Vaillant-Roussel, François Gueyffier, Jean‐Luc Faillie, M.-C. Pérault-Pochat et al. · 2016 · Diabetes & Metabolism
19. Systematic review of palm oil consumption and the risk of cardiovascular disease
    Sophia Rasheeqa Ismail, Siti Khuzaimah Maarof, Syazwani Siedar Ali, Azizan Ali · 2018 · PLoS ONE
20. ‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
    Mark A. Jarosinski, Balamurugan Dhayalan, Nischay K. Rege, Deepak Chatterjee, Michael Aaron Weiss · 2021 · Diabetologia
21. Retinal vascular changes and diabetic retinopathy
    Thanh T. Nguyen, Tien Yin Wong · 2009 · Current Diabetes Reports
22. Management Paradigms for Diabetic Macular Edema
    Paul Mitchell, Tien Yin Wong · 2013 · American Journal of Ophthalmology
23. Glycemic memory associated epigenetic changes
    Andrew L. Siebel, Ana Z. Fernández, Assam El‐Osta · 2010 · Biochemical Pharmacology
24. Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies
    Steven P. Marso, Jason B. Lindsey, Joshua M. Stolker, John A. House, Gabriela Martinez Ravn, Kevin F. Kennedy, Troels Mygind Jensen, John B. Buse · 2011 · Diabetes and Vascular Disease Research
25. Antidiabetic Medications and Polypharmacy
    Emily P. Peron, Kelechi C. Ogbonna, Krista L. Donohoe · 2014 · Clinics in Geriatric Medicine
26. The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes
    Merlin C. Thomas · 2017 · Diabetes & Metabolism
27. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
    Francesco Paneni, Thomas Felix Lüscher · 2017 · The American Journal of Medicine
28. Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty
    Satinder Singh, Ehrin J. Armstrong, Walid Sherif, Bejan A. Alvandi, Gregory G. Westin, Gagan Deep Singh, Ezra A. Amsterdam, John R. Laird · 2014 · Vascular Medicine
29. Real-world assessments of mySugr mobile health app
    Debong, Fredrick, Mayer, Harald, Kober, Johanna · 2019 · Diabetes Technology & Therapeutics
30. PPARα: an emerging therapeutic target in diabetic microvascular damage
    Hiukka, Anne, Maranghi, Marianna, Matikainen, Niina, Taskinen, Marja-Riitta · 2010 · Nature Reviews Endocrinology
31. Untitled work
    2023 · 10.1002/14651858.cd013775.pub2
32. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
    Clement Lo, Tadashi Toyama, Ying Wang, Jin Lin, Yoichiro Hirakawa, Min Jun, Alan Cass, Carmel Mary Hawley, Helen Pilmore, Sunil V. Badve et al. · 2018 · Cochrane Database of Systematic Reviews
33. Comparison between a basal‐bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER study
    Andreas Fritsche, Martin Larbig, David R. Owens, Hans‐Ulrich Häring, on behalf of the GINGER study group · 2009 · Diabetes Obesity and Metabolism
34. Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
    Hertzel C. Gerstein, Robert E. Ratner, Christopher Paul Cannon, Patrick W.J.C. Serruys, Hector Garcia-Garcia, Gerrit‐Anne van Es, Nikheel S. Kolatkar, Barbara G. Kravitz, Diane M. Miller, Chun Huang et al. · 2010 · Circulation
35. Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol
    Nichols, Gregory A, Philip, Sephy, Reynolds, Kristi, Granowitz, Craig B, Fazio, Sergio · 2018 · The Journal of Clinical Endocrinology & Metabolism
36. Cardiometabolic Comorbidities in Cancer Survivors
    Leah L. Zullig, Anthony Derek Sung, Michel Georges Khouri, Shelley A. Jazowski, Nishant P. Shah, Andrea Phillips Sitlinger, Dan V. Blalock, Colette A. Whitney, Robin Kikuchi, Hayden Barry Bosworth et al. · 2022 · JACC CardioOncology
37. Chronic kidney disease and diabetes.
    Ronald Pyram, Abhishek Kansara, M. Banerji, Lisel Loney-Hutchinson · 2012 · Maturitas
38. A1C and Cardiovascular Outcomes in Type 2 Diabetes
    Danielle C. Colayco, Fang Niu, Jeffrey S. McCombs, T. Craig Cheetham · 2010 · Diabetes Care
39. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: A systematic review for a KDOQI clinical practice guideline
    Slinin, Yelena, Ishani, Areef, Rector, Thomas, Fitzgerald, Patrick, MacDonald, Roderick, Tacklind, James, Rutks, Indulis, Wilt, Timothy J. · 2012 · American Journal of Kidney Diseases
40. Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
    Harold Edward Bays · 2013 · Diabetes Therapy
41. Can pulses play a role in improving cardiometabolic health? Evidence from systematic reviews and meta‐analyses
    Viguiliouk, Effie, Blanco Mejia, Sonia, Kendall, Cyril W.C., Sievenpiper, John L. · 2017 · Annals of the New York Academy of Sciences
42. Treatment of type 2 diabetes mellitus in the elderly
    Funda Datlı Yakaryılmaz, Zeynel Abidin Öztürk · 2017 · World Journal of Diabetes
43. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of type 2 diabetes mellitus - international task force
    Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid et al. · 2018 · Indian Journal of Endocrinology and Metabolism
44. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes
    Marcus Lind, Marita Olsson, Anders H. Rosengren, Ann‐Marie Svensson, Ioannis Bounias, Soffia Guðbjörnsdóttir · 2012 · Diabetologia
45. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
    Gerich · 2010 · Vascular Health and Risk Management
46. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications
    Neşe Ersöz Gülçelik, Jale Karakaya, Arzu Algün Gedik, Aydan Usman, Alper Gürlek · 2008 · European Journal of Endocrinology
47. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R. · 2021 · New England Journal of Medicine
48. Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control
    Muhammad Umer Nisar, Ambreen Asad, Ahmed Waqas, Nazia Ali, Anam Nisar, Mohsin A Qayyum, Hafsa Maryam, Mohsin Javaid, Mohsin Jamil · 2015 · Cureus
49. Serious Cardiovascular Outcomes in Diabetes
    Natalia Yakubovich, Hertzel C. Gerstein · 2011 · Circulation
50. Competing-Risk Analysis of ESRD and Death among Patients with Type 1 Diabetes and Macroalbuminuria
    Carol M. Forsblom, Valma Harjutsalo, Lena M. Thorn, Johan Wadén, Nina Tolonen, Markku Saraheimo, Daniel Gordin, John L. Moran, Merlin C. Thomas, Per‐Henrik Groop · 2011 · Journal of the American Society of Nephrology
51. The role of protein kinase C in diabetic microvascular complications
    Deng Pan, Lin Xu, Ming Hao Guo · 2022 · Frontiers in Endocrinology
52. Cardiovascular and autonomic phenotype of db/db diabetic mice
    Danielle Senador, Keerthy Kanakamedala, Maria Cláudia Irigoyen, Mariana Morris, Khalid M. Elased · 2009 · Experimental Physiology
53. The association between sustained HbA1c control and long-term complications among individuals with type 2 diabetes: a retrospective study
    Boye, Kristina S., Thieu, Vivian T., Lage, Maureen J., Miller, Heather, Paczkowski, Rosirene · 2022 · Advances in Therapy
54. Clinical Complexity in Middle-Aged and Older Adults With Diabetes: The Health and Retirement Study
    Blaum, Caroline S., Cigolle, Christine T., Boyd, Cynthia, Wolff, Jennifer L., Tian, Zhiyi, Langa, Kenneth M., Weir, David R. · 2010 · Medical Care
55. Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
    Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito · 2019 · Journal of the American Heart Association
56. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
    Jee Hee Yoo, Min Sun Choi, Jiyeon Ahn, Sung Woon Park, Yejin Kim, Kyu Yeon Hur, Sang‐Man Jin, Gyuri Kim, Jae Hyeon Kim · 2020 · Diabetes Technology & Therapeutics
57. Pathophysiological Fundamentals of Diabetic Cardiomyopathy
    Xinyue Hu, Tao Bai, Zheng Xu, Qiuju Liu, Yang Zheng, Lu Cai · 2017 · Comprehensive physiology
58. Cause-specific mortality in diabetes: recent changes in trend mortality
    Khalil, Charbel Abi, Roussel, Ronan, Mohammedi, Kamel, Danchin, Nicolas, Marre, Michel · 2012 · European Journal of Preventive Cardiology
59. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy
    Yuliya Sharkovska, Christoph Reichetzeder, Markus Alter, Oleg Tsuprykov, Sebastian Bachmann, Thomas Secher, Thomas Klein, Berthold Hocher · 2014 · Journal of Hypertension
60. Endothelial dysfunction in diabetes: multiple targets for treatment
    Hong Ding, Chris R. Triggle · 2010 · Pflügers Archiv - European Journal of Physiology
61. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up
    Helen Heneghan, Derrick C. Cetin, Sankar Dass Navaneethan, Neil Orzech, Stacy A. Brethauer, Philip R. Schauer · 2012 · Surgery for Obesity and Related Diseases
62. Glycemic Control and Extended Hemodialysis Survival in Patients with Diabetes Mellitus
    Mark E. Williams, Eduardo K. Lacson Jr., Weiling Wang, J. Michael Lazarus, Raymond M. Hakim · 2010 · Clinical Journal of the American Society of Nephrology
63. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
    Rhonda Bentley–Lewis, David A. Aguilar, Matthew C. Riddle, Brian Lee Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Peter Johnston, Lars Køber, Francesca C. Lawson et al. · 2015 · American Heart Journal
64. Diabetes, Dementia and Hypoglycemia
    Graydon S. Meneilly, Daniel Tessier · 2016 · Canadian Journal of Diabetes
65. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
    Ramzi Ajjan · 2017 · Diabetes Technology & Therapeutics
66. Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy
    Prodromos Parasoglou, Smita Rao, Jill M. Slade · 2017 · Clinical Therapeutics
67. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
    Shaofei Wang, Yubin Li, Jiajun Fan, Xuyao Zhang, Jingyun Luan, Qi Bian, Tao Ding, Yichen Wang, Ziyu Wang, Ping Song et al. · 2017 · Cell Death and Disease
68. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
    Guntram Schernthaner, Marie Helene Schernthaner-Reiter · 2018 · Diabetologia
69. Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
    Ferdinando Carlo Sasso, Luca Rinaldi, Nadia Lascar, Aldo Marrone, Pia Clara Pafundi, Luigi Elio Adinolfi, Raffaele Marfella · 2018 · Journal of Diabetes Research
70. Combined Task Delegation, Computerized Decision Support, and Feedback Improve Cardiovascular Risk for Type 2 Diabetic Patients
    Frits G.W. Cleveringa, Kees J. Gorter, Maureen van den Donk, Guy E.H.M. Rutten · 2008 · Diabetes Care
71. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis
    Christopher J. Hill, Alexander Peter Maxwell, Chris R. Cardwell, Barry I. Freedman, Marcello A. Tonelli, Masanori Emoto, Masaaki Inaba, Yasuaki Hayashino, Shunichi Fukuhara, Tomonari Okada et al. · 2013 · American Journal of Kidney Diseases
72. Update on biomarkers of glycemic control
    Krhač, Maja, Lovrenčić, Marijana Vučić · 2019 · World Journal of Diabetes
73. Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings
    Murphy, Mark E, Byrne, Molly, Galvin, Rose, Boland, Fiona, Fahey, Tom, Smith, Susan M · 2017 · BMJ Open
74. Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT
    T Terry, Kalyani Raravikar, Nalurporn Chokrungvaranon, Peter D. Reaven · 2011 · Current Cardiology Reports
75. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
    Guntram Schernthaner, Anthony H Barnett, D. J. Betteridge, Rafael Carmena, Antonio Ceriello, Bernard H. Charbonnel, Markolf Hanefeld E, Roger Lehmann, Maciej Tadeusz Malecki, Richard W. Nesto et al. · 2010 · Diabetologia
76. Pharmacologic Treatment of Type 2 Diabetes
    Linda Tran, Angela Zielinski, Arpi H. Roach, Jennifer A. Jende, Ann Marie Householder, Emily E. Cole, Shuruq A. Atway, Melinda Amornyard, Mallory L. Accursi, Suzanna W. Shieh et al. · 2015 · Annals of Pharmacotherapy
77. JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases
    Masakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, Takanori Ikeda, Kenji Ueshima, Shiro Uemura, Yutaka Otsuji, Yasuki Kihara, Kazuo Kimura, Takeshi Kimura et al. · 2021 · Circulation Journal
78. Biological Activities of Chinese Propolis and Brazilian Propolis on Streptozotocin‐Induced Type 1 Diabetes Mellitus in Rats
    Wei Jian Zhu, Minli Chen, Qiyang Shou, Yinghua Li, Fuliang Hu · 2010 · Evidence-based Complementary and Alternative Medicine
79. Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008
    J. Lobos, M. A. Royo-Bordonada, Carlos Brotons, L. Álvarez-Sala, Pedro Armario, A. Maiques, D. Mauricio, S. Sans, F. Villar, Ángel Lizcano et al. · 2008 · Revista Española de Salud Pública
80. Mortality Rates in Trials of Subjects With Type 2 Diabetes
    Ebrahim Barkoudah, Hicham Skali, Hajime Uno, Scott David Solomon, Marc Alan Pfeffer · 2012 · Journal of the American Heart Association
81. Genome-wide association study in a Chinese population with diabetic retinopathy
    Wayne Huey‐Herng Sheu, Jane Zea-Chin Kuo, I‐Te Lee, Yi‐Jen Hung, Wen‐Jane Lee, Hin-Yeung Tsai, Jun‐Sing Wang, Mark O. Goodarzi, Ronald Klein, Barbara E.K. Klein et al. · 2013 · Human Molecular Genetics
82. Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
    Cosmin Mihai Vesa, Loredana Popa, Amorin Remus Popa, Marius Rus, Andreea Atena Zaha, SIMONA GABRIELA BUNGAU, Delia Mirela Ţiţ, Raluca Anca Corb Aron, Dana Carmen Zaha · 2020 · Diagnostics
83. Advanced glycation end products and diabetic retinopathy
    Ross W. Milne, Seymour Brownstein · 2011 · Amino Acids
84. A Model for Predicting the Resolution of Type 2 Diabetes in Severely Obese Subjects Following Roux-en Y Gastric Bypass Surgery
    Mark Thomas Hayes, Lynette Hunt, Jonathan Foo, Yulia Tychinskaya, Richard Strawson Stubbs · 2011 · Obesity Surgery
85. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review
    Suzanne A. Ligthart, Edo Richard, Moll van Charante, Willem A. van Gool · 2010 · Vascular Health and Risk Management
86. Clinical adverse events associated with sodium-glucose cotransporter 2 inhibitors: a meta-analysis involving 10 randomized clinical trials and 71 553 individuals
    Lin, Donna Shu-Han, Lee, Jen-Kuang, Chen, Wen-Jone · 2021 · The Journal of Clinical Endocrinology & Metabolism
87. Do Veterans Health Administration Enrollees Generalize to Other Populations?
    Edwin S. Wong, Virginia Wang, Chuan‐Fen Liu, Paul L. Hebert, Matthew L. Maciejewski · 2015 · Medical Care Research and Review
88. Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c
    Xixiang Tang, Suhua Li, Yina Wang, Manman Wang, Qiongli Yin, Panwei Mu, Shuo Lin, Xiaoxian Qian, Xiaoming Ye, Yanming Chen · 2016 · Clinica Chimica Acta
89. Cerebrovascular complications of diabetes: focus on cognitive dysfunction
    Trevor Hardigan, Rebecca Ward, Adviye Ergul · 2016 · Clinical Science
90. The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Left Ventricular Function: Current Evidence and Future Directions
    Nick S.R. Lan, P. Gerry Fegan, Bu Beng Yeap, Girish Dwivedi · 2019 · ESC Heart Failure
91. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain
    Fernando Gómez Peralta, Timothy C. Dunn, Katherine Landuyt, Yongjin Xu, Juan Francisco Merino-Torres · 2020 · BMJ Open Diabetes Research & Care
92. Classification and Diagnosis of Diabetes
    SAUL M. GENUTH, Jerry P. Palmer, David M. Nathan · 2018
93. Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
    Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Luca Rinaldi, Francesca Coviello, Anna Di Martino, Gaetana Albanese, Raffaele Marfella, Celestino Sardu et al. · 2021 · Biomolecules
94. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes
    Franco Luigi Cavalot · 2013 · Diabetes Obesity and Metabolism
95. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study
    C. Raina Elley, Timothy W Kenealy, Elizabeth Robinson, P. L. Drury · 2008 · Diabetic Medicine
96. Economic and Clinical Impact of Inpatient Diabetic Hypoglycemia
    Suellen M. Curkendall, Jaime L. Natoli, Charles M. Alexander, Brian Harris Nathanson, Tracy Haidar, Robert W. Dubois · 2009 · Endocrine Practice
97. Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
    Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William, for the VADT Study Group · 2011 · Diabetes Care
98. Blood Pressure Control in Chronic Kidney Disease
    Julia Breyer Lewis · 2010 · Journal of the American Society of Nephrology
99. Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
    Yingnan Zhao, Claudia R. Campbell, Vivian Andrew Fonseca, Lizheng Shi · 2012 · Diabetes Care
100. Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer’s Disease? A Systematic Review and Meta-Analysis
     Susanna C. Larsson, Hugh Stephen Markus · 2018 · Journal of Alzheimer s Disease